People with Pi*MZ genotype have normal or mildly decreased serum AAT levels and are at much lower risk of developing a pathogenic liver fibrosis than Pi*ZZ individuals, but are still more susceptible to liver scaring than non-carriers, in particular when simultaneously suffering background liver disease (68, 69). Here, SERPINA1 is linked to Hepatic fibrosis.